[HTML][HTML] Uso de plasma de convalecientes para tratamiento de COVID-19: Historia y evidencia
F McAllister, A Mantegazza, F Garzón… - MEDICINA (Buenos …, 2020 - SciELO Argentina
COVID-19 es la enfermedad causada por el coronavirus SARS-CoV-2 (Severe Acute
Respiratory Syndrome Coronavirus 2). Los primeros casos se registraron a fines de 2019 en …
Respiratory Syndrome Coronavirus 2). Los primeros casos se registraron a fines de 2019 en …
[HTML][HTML] El plasma de convalecientes como un tratamiento potencial en pacientes con COVID-19
EC Rodríguez-Venegas, JE Fontaine-Ortiz… - Revista Cubana de …, 2021 - scielo.sld.cu
Objetivo: Realizar una revisión del empleo del plasma de convalecientes como alternativa
terapéutica a la COVID-19. Desarrollo: Se empleó la estrategia de búsqueda del tema; …
terapéutica a la COVID-19. Desarrollo: Se empleó la estrategia de búsqueda del tema; …
El plasma de convalecientes como un tratamiento potencial en pacientes con COVID-19
E de la Caridad Rodríguez-Venegas… - Revista Cubana de …, 2021 - revibiomedica.sld.cu
Objetivo: Realizar una revisión del empleo del plasma de convalecientes como alternativa
terapéutica a la COVID-19. Desarrollo: Se empleó la estrategia de búsqueda del tema; …
terapéutica a la COVID-19. Desarrollo: Se empleó la estrategia de búsqueda del tema; …
[HTML][HTML] Terapia de plasma convaleciente para pacientes con Covid-19: Revisión de la literatura
T Platero-Portillo, S Llocclla-Delgado… - Revista de la Facultad …, 2020 - scielo.org.pe
Introducción: La enfermedad por coronavirus 2019 (COVID-19) causada por la infección por
el nuevo coronavirus (SARS-CoV-2) ha creado una pandemia que ha llevado a una lucha …
el nuevo coronavirus (SARS-CoV-2) ha creado una pandemia que ha llevado a una lucha …
[HTML][HTML] Uso de plasma convaleciente en pacientes con COVID-19
NM Nina Garcia, GA Cussi Coronel - Gaceta Médica Boliviana, 2020 - scielo.org.bo
La enfermedad por coronavirus 2019 (COVID-19) representa una de las mayores
pandemias a las que el mundo se enfrenta y está produciendo una crisis sanitaria global …
pandemias a las que el mundo se enfrenta y está produciendo una crisis sanitaria global …
[HTML][HTML] Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks
DJ Wooding, H Bach - Clinical Microbiology and Infection, 2020 - Elsevier
Background There is currently no treatment known to alter the course of coronavirus disease
2019 (COVID-19). Convalescent plasma has been used to treat a number of infections …
2019 (COVID-19). Convalescent plasma has been used to treat a number of infections …
[PDF][PDF] Transfusión de plasma convaleciente de pacientes con COVID-19
CA Galván, C Toribio-Dionicio… - Revista Peruana de …, 2020 - SciELO Public Health
There is currently no vaccine available and no specific medication against Coronavirus
2019 disease (COVID-19). The treatment is mainly based on support measures. In this …
2019 disease (COVID-19). The treatment is mainly based on support measures. In this …
Safety and efficacy of convalescent plasma for COVID-19: the preliminary results of a clinical trial
VP Baklaushev, AV Averyanov… - Journal of Clinical …, 2020 - journals.eco-vector.com
Background. The lack of effective etiotropic therapy for COVID-19 has prompted researchers
around the globe to seekr various methods of SARS-CoV-2 elimination, including the use of …
around the globe to seekr various methods of SARS-CoV-2 elimination, including the use of …
[HTML][HTML] Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized …
E Diago-Sempere, JL Bueno, A Sancho-López… - Trials, 2021 - Springer
Background COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-
2) and causes substantial morbidity and mortality. At the time this clinical trial was planned …
2) and causes substantial morbidity and mortality. At the time this clinical trial was planned …
Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19
JA Al-Tawfiq, Y Arabi - Human Vaccines & Immunotherapeutics, 2020 - Taylor & Francis
The emergence of the COVID-19 pandemic has resulted in a very large number of infections
and high number of mortality. There is no specific therapeutic options that are approved for …
and high number of mortality. There is no specific therapeutic options that are approved for …